Ligandal
Brooklyn
About Ligandal
Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.6M
- Funding stage: Seed
- Last round: Seed (Feb 2019)
- Website: ligandal.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/ligandal-35656 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.